FIGURE 7.
Effect of Dmab discontinuation strategies on bone apparent density and damage: 1) 60Q6 Dmab treatment discontinued after 5 years (black), 2) 60Q6 Dmab treatment with a decreasing dose (50, 40, 30, 20 and 10 mg) for the last 5 injections (green), 3) 60Q6 Dmab treatment switched to BP after 5 years (red), 4) 60Q6 Dmab treatment with a decreasing dose (50, 40, 30, 20 and 10 mg) for the last 5 injections and combined with BP from dose 30 mg onwards (blue).